Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**DYURAL L KIT** is an unapproved combination injection kit containing methylprednisolone acetate, lidocaine hydrochloride, isopropyl alcohol, and povidone-iodine. Methylprednisolone acetate is a synthetic glucocorticoid that activates the glucocorticoid receptor to suppress inflammatory and immune-mediated signaling. Lidocaine hydrochloride provides local anesthesia through reversible inhibition of voltage-gated sodium channels, while isopropyl alcohol and povidone-iodine are included for antiseptic skin preparation before injection. The kit is intended to support intramuscular, intra-articular, soft-tissue, or intralesional corticosteroid administration for inflammatory, allergic, rheumatologic, dermatologic, and other corticosteroid-responsive disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lidocaine hydrochloride + isopropyl alcohol + povidone-iodine + methylprednisolone.